ASSERTIO THERAPEUTICS

IL

Pharmaceuticals

Active 2018–2019.

Filings
7
Filed By
1
Reported In-House
—
Reported By Firms
$270,000

Filings

YearFirmPeriodAmountDoc
2019 VENN STRATEGIES 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Termination (No Activity)
—
2019 VENN STRATEGIES 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$70,000
2019 VENN STRATEGIES 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$40,000
2019 VENN STRATEGIES 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$90,000
2018 VENN STRATEGIES 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$70,000
2018 VENN STRATEGIES 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
—
2018 VENN STRATEGIES 3rd Quarter (July 1 - Sep 30)
Registration
—
Filed By
FirmFilingsAmount
VENN STRATEGIES 7 $270,000
Issue Areas
IssueActivities
Health Issues 6